Annex VI LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS
United Kingdom
Not required if concentration is 0,5 % or less and when it is used only for product protection purposes. | ||||||||
F1For use as a colorant, see Annex IV, No 143. | ||||||||
F2In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit given in column g. | ||||||||
F3In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g. | ||||||||
F4In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g. | ||||||||
| Reference number | Substance identification | Conditions | Wording of conditions of use and warnings | |||||
|---|---|---|---|---|---|---|---|---|
| Chemical name/INN/XAN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, body parts | Maximum concentration in ready for use preparation | Other | ||
| a | b | c | d | e | f | g | h | i |
| F51 | ||||||||
| 2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulfate | Camphor Benzalkonium Methosulfate | 52793-97-2 | 258-190-8 | 6 % | |||
| 3 | Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester/Homosalate | Homosalate | 118-56-9 | 204-260-8 | 10 % | |||
| F64 | 2-Hydroxy-4-methoxybenzophenone/Oxybenzone | Benzophenone-3 | 131-57-7 | 205-031-5 | F7Product types— (a) skin products, other than those listed in paragraph (b), including all propellant and pump spray skin products; (b) face products, hand products and lip products (excluding propellant and pump spray face products, hand products and lip products); (c) all other cosmetic products. | F8For product types— (a) 2.2%; (b) 6%; (c) 0.5%. | F9For product types (a) and (b), not to be used at more than 0.5% to protect product formulation. If used at 0.5% to protect product formulation, the levels used as UV filter must not exceed, for product types— (a) 1.7%; (b) 5.5%. | Contains Benzophenone-3 f1 |
| 5 | Moved or deleted | |||||||
| 6 | 2-Phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts/Ensulizole | Phenylbenzimidazole Sulfonic Acid | 27503-81-7 | 248-502-0 | 8 %(as acid) | |||
| 7 | 3,3'-(1,4-Phenylenedimethylene) bis(7, 7-dimethyl-2-oxobicyclo-[2.2.1]hept-1-yl-methanesulfonic acid) and its salts/Ecamsule | Terephthalylidene Dicamphor Sulfonic Acid | 92761-26-7, 90457-82-2 | 410-960-6 | 10 %(as acid) | |||
| 8 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione/Avobenzone | Butyl Methoxydibenzoylmethane | 70356-09-1 | 274-581-6 | 5 % | |||
| 9 | alpha-(2-Oxoborn-3-ylidene)-toluene-4-sulphonic acid and its salts | Benzylidene Camphor Sulfonic Acid | 56039-58-8 | 6 % (as acid) | ||||
| 10 | 2-Cyano-3,3-diphenyl acrylic acid, 2-ethylhexyl ester/Octocrilene | Octocrylene | 6197-30-4 | 228-250-8 | 10 % (as acid) | |||
| 11 | Polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl} acrylamide | Polyacrylamidomethyl Benzylidene Camphor | 113783-61-2 | 6 % | ||||
| 12 | 2-Ethylhexyl 4-methoxycinnamate/Octinoxate | Ethylhexyl Methoxycinnamate | 5466-77-3 | 226-775-7 | 10 % | |||
| 13 | Ethoxylated ethyl-4-aminobenzoate | PEG-25 PABA | 116242-27-4 | 10 % | ||||
| 14 | Isopentyl-4-methoxycinnamate/Amiloxate | Isoamyl p-Methoxycinnamate | 71617-10-2 | 275-702-5 | 10 % | |||
| 15 | 2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine | Ethylhexyl Triazone | 88122-99-0 | 402-070-1 | 5 % | |||
| 16 | Phenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyl)oxy)-disiloxanyl)propyl) | Drometrizole Trisiloxane | 155633-54-8 | 15 % | ||||
| 17 | Benzoic acid, 4,4-((6-((4-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-triazine-2,4-diyl)diimino)bis-, bis (2-ethylhexyl) ester/Iscotrizinol (USAN) | Diethylhexyl Butamido Triazone | 154702-15-5 | 10 % | ||||
| F10... | ... | ... | ... | ... | ... | |||
| F11... | ||||||||
| 20 | 2-Ethylhexyl salicylate/Octisalate | Ethylhexyl Salicylate | 118-60-5 | 204-263-4 | 5 % | |||
| 21 | 2-Ethylhexyl 4-(dimethylamino)benzoate/Padimate O (USAN:BAN) | Ethylhexyl Dimethyl PABA | 21245-02-3 | 244-289-3 | 8 % | |||
| 22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt/Sulisobenzone | Benzophenone-4, Benzophenone-5 | 4065-45-6/6628-37-1 | 223-772-2 / - | 5 % (as acid) | |||
| F1223 | 2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole | Methylene Bis-Benzotriazolyl Tetramethylbutylphenol | 103597-45-1 | 403-800-1 | 10 % f2 | |||
| 23a | 2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole | Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano) | 103597-45-1 | 403-800-1 | 10 % | Not to be used in applications that may lead to exposure of the end user's lungs by inhalation. Only nanomaterials having the following characteristics are allowed:
| ||
| 24 | Sodium salt of 2,2'-bis(1,4-phenylene)-1H-benzimidazole-4,6-disulfonic acid) / Bisdisulizole disodium (USAN) | Disodium Phenyl Dibenzimidazole Tetrasulfonate | 180898-37-7 | 429-750-0 | 10 % (as acid) | |||
| 25 | 2,2'-(6-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diyl)bis(5-((2-ethylhexyl)oxy)phenol) / Bemotrizinol | Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine | 187393-00-6 | 10 % | ||||
| 26 | Dimethicodiethylbenzalmalonate | Polysilicone-15 | 207574-74-1 | 426-000-4 | 10 % | |||
| 27 | Titanium dioxide f3 | Titanium Dioxide | 13463-67-7/ 1317-70-0/ 1317-80-2 | 236-675-5/ 215-280-1/ 215-282-2 | 25 % f4 | |||
| F1327a | Titanium dioxide | Titanium Dioxide (nano) | 13463-67-7/1317-70-0/1317-80-2 | 236-675-5/215-280-1/215-282-2 | 25 % | Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Only nanomaterials having the following characteristics are allowed:
or coated with one of the following combinations:
| For face products containing Titanium Dioxide (nano) coated with the combination Alumina and Manganese Dioxide: Not to be used on the lips. | |
| 28 | Benzoic acid, 2-[-4-(diethylamino)-2-hydroxybenzoyl]-. Hexylester | Diethylamino Hydroxy benzoyl Hexyl Benzoate | 302776-68-7 | 443-860-6 | 10 % | |||
| F14X129 | 1,3,5-Triazine, 2,4,6-tris[1,1'-biphenyl]-4-yl-, including as nanomaterial | Tris-biphenyl triazine Tris-biphenyl triazine (nano) | 31274-51-8 | — | 10 % | Not to be used in sprays. Only nanomaterials having the following characteristics are allowed:
| ||
| 30 | Zinc oxide | Zinc Oxide | 1314-13-2 | 215-222-5 | 25 % f5 | Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. | ||
| 30a | Zinc oxide | Zinc Oxide (nano) | 1314-13-2 | 215-222-5 | 25 % | Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. Only nanomaterials having the following characteristics are allowed:
| ||
| F1531 | 3,3′-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine) | Phenylene Bis-Diphenyltriazine | 55514-22-2 | 700-823-1 | 5 % | Not to be used in applications that may lead to exposure of the end user's lungs by inhalation. | ||
| F1632 | 2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate | Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate | 1419401-88-9 | 700-860-3 | 3 % |
| ||
| F1733 | 1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine | 919803-06-8 | 485-100-6 | 10% | In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. | ||
| 34 | 11,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano) | 919803-06-8 | 485-100-6 | 10% | Only nanomaterials having the following characteristics are allowed:
Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. | ||
Annotations
Textual amendments
- F1
- F2
- F3
- F4
- F5
- F6
- F7
Words in Annex 6 table inserted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(a) (with reg. 3)
- F8
Words in Annex 6 table substituted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(b) (with reg. 3)
- F9
Words in Annex 6 table substituted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(c) (with reg. 3)
- F10
Words in Annex 6 table omitted (E.W.S.) (15.7.2026) by virtue of The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026 (S.I. 2026/23), regs. 1(2), 2(5) (with reg. 3)
- F11
- F12
- F13
- F14
- F15
- F16
- F17
Words in Annex 6 inserted (9.8.2023) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2023 (S.I. 2023/836), regs. 1(2), 3(3), Sch. 2
Editorial notes
Footnotes
- f1
Not required if concentration is 0,5 % or less and when it is used only for product protection purposes.
- f2
In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g.
- f3
For use as a colorant, see Annex IV, No 143.
- f4
In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g.
- f5
In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit given in column g.